Mar 28, 2019

Jury orders Bayer to pay cancer victim $80 million

Edwin Hardeman, who sued Bayer. Photo: Julie Charpentrat/Getti Images

A federal jury in San Francisco said Wednesday that Bayer — which acquired Monsanto last year — must pay roughly $80 million in damages to a California man said to have contracted cancer after exposure to the company’s Roundup weedkiller, per The Wall Street Journal.

Details: This marks the second verdict issued against the company after a jury last summer said Roundup caused cancer, ultimately ordering the company to pay $78.6 million in damages. In Wednesday's ruling, the jury said Bayer was negligent and failed to adequately warn the public about the product’s risks. The company reportedly plans to appeal the verdict, adding that it stands behind its products and will vigorously defend them.

Go deeper

Coronavirus kills 2 Diamond Princess passengers and South Korea sees first death

Data: The Center for Systems Science and Engineering at Johns Hopkins, the CDC, and China's Health Ministry. U.S. numbers include Americans extracted from Princess Cruise ship.

Two elderly Diamond Princess passengers have been killed by the novel coronavirus — the first deaths confirmed among the more than 600 infected aboard the cruise ship. South Korea also announced its first death Thursday.

The big picture: COVID-19 has now killed more than 2,200 people and infected over 75,465 others, mostly in mainland China, where the National Health Commission announced 118 new deaths since Thursday.

Go deeperArrowUpdated 8 hours ago - Health

SoftBank to cut its stake to get T-Mobile's Sprint deal done

Illustration: Rebecca Zisser/Axios

T-Mobile and Sprint announced a revised merger agreement that will see SoftBank getting a smaller share of the combined company, while most shareholders will receive the previously agreed upon exchange rate. The companies said they hope to get the deal as early as April 1.

Why it matters: The amended deal reflects the decline in Sprint's business, while leaving most shareholders' stake intact and removing another hurdle to the deal's closure.